Sertraline Completed Phase 4 Trials for Dysthymic Disorder / Depression Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00234312Medications for the Treatment of Dysthymic Disorder and Double Depression
NCT00834652Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight
NCT00508859Maintenance Study for Adolescent Depression
NCT00666757A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression
NCT02901249Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder
NCT01477268Cognitive Correlates of Antidepressant Treatment Response in Elders
NCT02228005The Effect of a Selective Serotonin Reuptake Inhibitor on Gait, Balance, and Bone Metabolism in Older Adults
NCT00021528Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
NCT00375843Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication